Astria Therapeutics, Inc.
ATXSDelisted Jan 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001454789
Astria Therapeutics, Inc. was delisted on Jan 23, 2026; its insiders filed their last Form 4 on Jan 23, 2026; 141 institutions reported holding it in 13F filings for Q4 2025, worth $738.2M in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q3 2022
Institutional positions in Astria Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- +13 vs. Q2 2022
- Shares held
- 9.83M
- +4.10M (+71.5%) vs. Q2 2022
- Total value
- $88.8M
- +$71.7M (+416.7%) vs. Q2 2022
- New holders
- 15
- 11 more added
- Sold out
- 2
- 8 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ATXS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 141 | $738.2M |
| Q3 2025 | 115 | $409.0M |
| Q2 2025 | 106 | $309.9M |
| Q1 2025 | 116 | $311.4M |
| Q4 2024 | 111 | $523.4M |
| Q3 2024 | 103 | $622.1M |
| Q2 2024 | 100 | $505.8M |
| Q1 2024 | 102 | $810.6M |
| Q4 2023 | 80 | $282.6M |
| Q3 2023 | 68 | $171.4M |
| Q2 2023 | 76 | $205.5M |
| Q1 2023 | 66 | $311.6M |
| Q4 2022 | 61 | $326.1M |
| Q3 2022 | 43 | $88.8M |
| Q2 2022 | 30 | $17.2M |
| Q1 2022 | 33 | $41.7M |
| Q4 2021 | 33 | $32.8M |
| Q3 2021 | 36 | $65.2M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Astria Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 1,281,197 | $11.6M | 0.34% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 1,200,000 | $10.8M | 0.76% | +900,000+300.0% | Added |
| Vivo Capital, LLC | 1,000,000 | $9.04M | 1.00% | +1,000,000 | New |
| Fairmount Funds Management LLC | 911,736 | $8.24M | 1.52% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 699,440 | $6.32M | 3.16% | +107,317+18.1% | Added |
| Driehaus Capital Management LLC | 656,361 | $5.93M | 0.09% | +656,361 | New |
| Tri Locum Partners LP | 631,579 | $5.71M | 1.63% | +631,579 | New |
| Vanguard Group Inc | 531,153 | $4.80M | 0.00% | +27,743+5.5% | Added |
| Ghost Tree Capital, LLC | 500,000 | $4.52M | 1.85% | +500,000 | New |
| Altium Capital Management LP | 445,000 | $4.02M | 1.51% | +445,000 | New |
| Affinity Asset Advisors, LLC | 400,043 | $3.62M | 1.67% | +400,043 | New |
| FMR LLC | 377,445 | $3.41M | 0.00% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 274,719 | $2.48M | 0.03% | 00.0% | Unchanged |
| Opaleye Management Inc. | 133,500 | $1.21M | 0.50% | +133,500 | New |
| Citadel Advisors LLC | 122,476 | $1.11M | 0.00% | −97,486−44.3% | Reduced |
| Geode Capital Management, LLC | 111,905 | $1.01M | 0.00% | +27,709+32.9% | Added |
| Boothbay Fund Management, LLC | 101,619 | $919.0K | 0.03% | +25,846+34.1% | Added |
| BlackRock Inc. | 78,325 | $708.0K | 0.00% | +16,868+27.4% | Added |
| Renaissance Technologies LLC | 57,861 | $523.0K | 0.00% | +44,161+322.3% | Added |
| Bridgeway Capital Management, LLC | 35,000 | $316.0K | 0.01% | −79,279−69.4% | Reduced |
| Artal Group S.A. | 33,333 | $301.0K | 0.02% | 00.0% | Unchanged |
| State Street Corp | 29,082 | $263.0K | 0.00% | +29,082 | New |
| Samsara BioCapital, LLC | 25,000 | $226.0K | 0.05% | 00.0% | Unchanged |
| Botty Investors LLC | 24,331 | $220.0K | 0.09% | −1,416−5.5% | Reduced |
| Jane Street Group, LLC | 21,498 | $194.0K | 0.00% | +21,498 | New |
| Millennium Management LLC | 20,710 | $187.0K | 0.00% | +3,793+22.4% | Added |
| Northern Trust Corp | 19,593 | $177.0K | 0.00% | −316−1.6% | Reduced |
| Oppenheimer & Co Inc | 17,816 | $161.0K | 0.00% | −5,800−24.6% | Reduced |
| Dimensional Fund Advisors LP | 17,521 | $158.0K | 0.00% | +17,521 | New |
| Cubist Systematic Strategies, LLC | 14,666 | $133.0K | 0.00% | +14,666 | New |
| Jump Financial, LLC | 12,000 | $108.0K | 0.00% | +12,000 | New |
| Acadian Asset Management LLC | 11,461 | $103.0K | 0.00% | +11,461 | New |
| Morgan Stanley | 10,705 | $97.0K | 0.00% | +8,204+328.0% | Added |
| Group One Trading, L.P. | 8,500 | $77.0K | 0.00% | −2,931−25.6% | Reduced |
| Bank of America Corp | 8,092 | $73.0K | 0.00% | +7,527+1,332.2% | Added |
| UBS Group AG | 3,262 | $29.0K | 0.00% | +3,237+12,948.0% | Added |
| Tower Research Capital LLC (TRC) | 793 | $7.00K | 0.00% | −1,280−61.7% | Reduced |
| Benjamin F. Edwards & Company, Inc. | 333 | $3.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 299 | $3.00K | 0.00% | +299 | New |
| BNP Paribas Arbitrage, SA | 119 | $1.08K | 0.00% | +119 | New |
| Wells Fargo & Company | 60 | $1.00K | 0.00% | −4−6.3% | Reduced |
| Key Financial Inc | 66 | $1.00K | 0.00% | 00.0% | Unchanged |
| SOA Wealth Advisors, LLC. | 7 | $0 | 0.00% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −760,857−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −77−100.0% | Sold out |